Validation of a single-sample urinary C-peptide creatinine ratio as a reproducible alternative to serum C-peptide in patients with Type 2 diabetes

Diabetic Medicine

Volumn 29, Issue 1, 2012, Pages 90-93

  Bowman, P ^a   McDonald, T J ^a,b   Shields, B M ^a   Knight, B A ^a   Hattersley, A T ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

C peptide; Reproducibility; Type 2 diabetes; Urine

Indexed keywords

C PEPTIDE; C PEPTIDE CREATININE; CREATINE; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; URINALYSIS;

ADULT; BIOLOGICAL MARKERS; C-PEPTIDE; CREATININE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INSULIN; MALE; POSTPRANDIAL PERIOD; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS;

EID: 83155182351     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2011.03428.x     Document Type: Article

References (13)

1. Madsbad S, Krarup T, McNair P, Christiansen C, Faber OK, Transbol I et al. Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus. Acta Med Scand 1981; 210: 153-156.
2. Koskinen PJ, Viikari JS, Irjala KM. Glucagon-stimulated and postprandial plasma C-peptide values as measures of insulin secretory capacity. Diabetes Care 1988; 11: 318-322.
3. Prando R, Odetti P, Melga P, Giusti R, Ciuchi E, Cheli V. Progressive deterioration of beta-cell function in no-nobese type2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency. Diabetes Metab 1996; 22: 185-191.
4. Clark PM. Assays for insulin, proinsulin(s) and C-peptide. Ann Clin Biochem 1999; 36: 541-564.
5. McDonald TJ, Knight BA, Shields BM, Bowman P, Salzmann MB, Hattersley AT. Stability and reproducibility of a single-sample urinary C-peptide/creatinine ratio and its correlation with 24-h urinary C-peptide. Clin Chem 2009; 55: 2035-2039.
6. Koskinen P, Viikari J, Irjala K, Kaihola HL, Seppala P. Plasma and urinary C-peptide in the classification of adult diabetics. Scand J Clin Lab Invest 1986; 46: 655-663.
7. Besser RE, Ludvigsson J, Jones AG, McDonald TJ, Shields BM, Knight BA et al. Urine C-peptide creatinine ratio is a non-invasive alternative to the mixed-meal tolerance test in children and adults with type1 diabetes. Diabetes Care 2011; 34: 607-609.
8. Jones AG, Besser RE, McDonald TJ, Shields BM, Hope SV, Bowman P et al. Urine C-peptide creatinine ratio is an alternative to stimulated serum C-peptide measurement in late-onset, insulin-treated diabetes. Diabet Med 2011; 28: 1034-1038.
9. Besser RE, Shepherd MH, McDonald TJ, Shields BM, Knight BA, Ellard S et al. Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1α/hepatocyte nuclear factor 4-α maturity-onset diabetes of the young from long-duration type 1 diabetes. Diabetes Care 2011; 34: 286-291.
10. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
11. Gero L, Koranyi L, Tamas G Jr. Residual B-cell function in insulin-dependent (Type1) and non-insulin-dependent (Type2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes). Diabetes Metab 1983; 9: 183-187.
12. Fernandez-Castaner M, Rosel P, Ricart W, Montana E, Gomez JM, Navarro MA et al. Evaluation of B-cell function in diabetics by C-peptide determination in basal and postprandial urine. Diabetes Metab 1987; 13: 538-542.
13. Aoki Y. Variation of endogenous insulin secretion in association with treatment status: assessment by serum C-peptide and modified urinary C-peptide. Diabetes Res Clin Pract 1991; 14: 165-173.